Page last updated: 2024-11-07

cui xing ning

Description Research Excerpts Clinical Trials Roles Classes Pathways Study Profile Bioassays Related Drugs Related Conditions Protein Interactions Research Growth

Description

cui xing ning: RN given is for parent compound [Medical Subject Headings (MeSH), National Library of Medicine, extracted Dec-2023]

Cross-References

ID SourceID
PubMed CID132200
MeSH IDM0106920

Synonyms (8)

Synonym
carbaindoline
5-(1,3,3-trimethylindoline)-n,n-dimethylcarbamate
5-(1,3,3-trimethylindolinyl)-n,n-dimethylcarbamate
139052-05-4
carbamic acid, dimethyl-, 2,3-dihydro-1,3,3-trimethyl-1h-indol-5-yl ester, monohydrochloride
cui xing ning
DTXSID40160879
(1,3,3-trimethyl-2h-indol-5-yl) n,n-dimethylcarbamate;hydrochloride

Research Excerpts

Dosage Studied

ExcerptRelevanceReference
"kg-1) shifted the dose-response curve of xylazine induced sedation to the right, hemicholinum-3 (3 micrograms icv), which inhibits the synthesis of acetylcholine, shifted the dose-response curve to the left."( [Antagonistic effects of cholinergic drugs on xylazine induced sedation].
Ding, RG; Huang, SJ; Yang, JS, 1993
)
0.29
[information is derived through text-mining from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Research

Studies (5)

TimeframeStudies, This Drug (%)All Drugs %
pre-19901 (20.00)18.7374
1990's4 (80.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Study Types

Publication TypeThis drug (%)All Drugs (%)
Trials0 (0.00%)5.53%
Reviews0 (0.00%)6.00%
Case Studies0 (0.00%)4.05%
Observational0 (0.00%)0.25%
Other5 (100.00%)84.16%
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]